Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-15 Sale |
2025-01-15 4:18 pm |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
12,991 | $0.5748 | $7,467 | 18,421 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-18 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
24,531 | $0.93 | $22,814 | 38,293 (Direct) |
View |
| 2023-01-31 Sale |
2023-01-31 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
11,890 | $1.8696 | $22,230 | 19,535 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-01 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
21,040 | $1.7735 | $37,314 | 34,824 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-20 Option Award |
2025-02-20 5:32 pm |
N/A 2035-02-20 |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
2,686,728 | $0 | 2,686,728 (Direct) |
View |
| 2024-03-18 Option Award |
2024-03-18 5:00 pm |
N/A 2034-03-18 |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
6,219,696 | $0 | 6,219,696 (Direct) |
View |
| 2023-07-03 Option Award |
2023-07-05 5:00 pm |
N/A 2033-07-03 |
Allovir Inc. | ALVR | Piccina Cintia Chief Commercial Officer |
420,000 | $0 | 420,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:02 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
1,902,888 | $0 | 1,902,888 (Direct) |
View |
| 2022-01-31 Option Award |
2022-01-31 9:05 pm |
N/A 2032-01-31 |
Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer |
4,466,376 | $0 | 4,466,376 (Direct) |
View |